US20210386056A1 - Tissue sample coring system - Google Patents
Tissue sample coring system Download PDFInfo
- Publication number
- US20210386056A1 US20210386056A1 US17/348,504 US202117348504A US2021386056A1 US 20210386056 A1 US20210386056 A1 US 20210386056A1 US 202117348504 A US202117348504 A US 202117348504A US 2021386056 A1 US2021386056 A1 US 2021386056A1
- Authority
- US
- United States
- Prior art keywords
- well
- storage container
- cryogenic storage
- tray
- identification feature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003860 storage Methods 0.000 claims abstract description 57
- 239000011159 matrix material Substances 0.000 claims description 9
- 238000012546 transfer Methods 0.000 claims description 8
- 238000005516 engineering process Methods 0.000 abstract description 22
- 239000000523 sample Substances 0.000 description 21
- 230000008014 freezing Effects 0.000 description 8
- 238000007710 freezing Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000012595 freezing medium Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000000495 cryogel Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000006525 intracellular process Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0236—Mechanical aspects
- A01N1/0263—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving, e.g. cool boxes, blood bags or "straws" for cryopreservation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0096—Casings for storing test samples
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0236—Mechanical aspects
- A01N1/0242—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components
- A01N1/0252—Temperature controlling refrigerating apparatus, i.e. devices used to actively control the temperature of a designated internal volume, e.g. refrigerators, freeze-drying apparatus or liquid nitrogen baths
- A01N1/0257—Stationary or portable vessels generating cryogenic temperatures
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0236—Mechanical aspects
- A01N1/0263—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving, e.g. cool boxes, blood bags or "straws" for cryopreservation
- A01N1/0268—Carriers for immersion in cryogenic fluid, both for slow-freezing and vitrification, e.g. open or closed "straws" for embryos, oocytes or semen
Definitions
- the present technology generally relates to systems and methods for storing cryogenic tissue samples in a storage container and identifying the samples.
- FFPE formalin fixed tissues
- Tissue biopsies are among the most common medical procedures used to establish diagnosis. Historically, tissue biopsies were primarily used for histology. More recently, with increasing understanding of molecular basis of disease, tissue samples are being used in personalized medicine where treatments are based on discoveries of molecular biomarkers.
- Cryogenic tissues are typically stored in tubes (often 1.5 ml), but typically only a small space is occupied on the bottom tip of the tube, leading to inefficient freezer storage.
- the frozen tissue samples freeze attached to the bottom of the tube, and removal often requires a degree of thawing. Repeated thawing and freezing can cause sample degradation.
- FIG. 1 is an exploded perspective view of a tissue sample storage container grid assembly configured in accordance with an embodiment of the present technology.
- FIG. 2 is an enlarged perspective view of the tissue sample storage container of FIG. 1 , showing a compartment lid open.
- FIG. 3 is a perspective view of a tissue sample storage container grid configured in accordance with an embodiment of the present technology.
- FIG. 4 is a front view of the tissue sample storage container grid of FIG. 3 .
- FIG. 5 is a front view of a tray portion of the tissue sample storage container grid of FIG. 3 , showing an identifying corner.
- the present technology is directed to a cryogenic tissue sample storage system having a tissue sample storage container grid.
- Storage systems of the present technology increase the density of tissue samples per volume to allow a greater number of samples to be stored in freezers.
- the relatively shallow storage wells increase accessibility of the samples and avoid the degradation of a thaw and refreeze cycle of the cryogenic sample.
- Tissue sample storage containers configured in accordance with the present technology maintain the cores in a frozen state and provide catalog information for identification of the cores in each well.
- Frozen tissue sample blocks from which cores are extracted by a coring tool may be contained within a grid of cryogenically temperature-controlled sample wells.
- Storage container grids configured in accordance with the present technology may be adapted to store and organize tissue samples in a space-efficient manner for coring and testing.
- the frozen tissue samples can be kept in a frozen state by any suitable heat removal method, such as placing the storage grid in an enclosure (e.g., a freezer) or a chilled component, and/or contacting the storage grid with a cold substance (e.g., solid carbon dioxide, “dry ice,” etc.).
- the storage grid may have active heat removal to keep the tissue samples at a specified temperature for long-term storage.
- FIG. 1 is an exploded perspective view of a tissue sample storage container grid assembly 100 (“grid assembly 100 ”) configured in accordance with an embodiment of the present technology.
- the grid assembly 100 includes a lid 110 , a tray 120 , and a base 130 .
- the components of the grid assembly 100 are separable, such that one or more components may be used without the full assembly, e.g., using the lid 110 and the tray 120 together and placing the subassembly of the lid 110 and the tray 120 in a freezer without the base 130 .
- the lid 110 has an array of individual openings 112 generally arranged in a grid along the surface of the lid 110 .
- Each of the openings 112 can include a cover or semi- to fully transparent door 114 configured to occlude the corresponding opening 112 when the opening is not in use, after the tissue samples have been placed within the grid assembly 100 , during storage, etc.
- the door 114 can be hingedly coupled to the lid 110 (as shown in FIG. 2 ) or can be detachable from the lid 110 .
- the lid 110 can further include an identification feature (e.g., a barcode 116 ) near each of the openings 112 configured to identify the tissue sample stored within a particular position of the grid assembly 100 .
- the tray 120 includes an array of wells 122 generally corresponding to the position of the openings 112 of the lid 110 .
- the wells 122 are sized and configured to enclose tissue samples together with the doors 114 .
- each well 122 is shown in the Figures having a rounded-rectangular shape, the wells can have any suitable shape, such as circular, elliptical, triangular, geometric, etc.
- Each well 122 is defined by walls 125 extending from a perimeter aligned with the openings 112 , and a bottom portion 126 .
- the wall 125 and/or the bottom portion 126 of the wells 122 can include one or more perforations 124 to increase the heat transfer from the tissue samples inside of the wells 122 to the base 130 , e.g., while extracting heat during freezing, or to another heat transfer component.
- the tray 120 can include one or more mechanical coupling features (not shown) that correspond to features on the lid 110 and provide a removable coupling of the lid 110 on the tray 120 . In this regard the subassembly of the lid 110 and the tray 120 can be removed from the base 130 without separating the lid 110 and the tray 120 , retaining the tissue samples within the wells 122 .
- the tray 120 can be formed from plastic sheets (e.g., polystyrene, polycarbonate, etc.) and molded into skirted rectangular trays that contain the wells 122 for storing the tissue samples.
- the lid 110 and tray 120 can be made from any suitable material, such as a plastic (e.g., polystyrene, polypropylene, etc.), metal, etc.
- the base 130 includes an array of pockets 132 generally corresponding to the position of the openings 112 of the lid 110 and the wells 122 of the tray 120 .
- the pockets 132 are sized and configured to receive the wells 122 therein, and may contact one or more of the outer surfaces of the wells 122 (e.g., the walls 125 and/or the bottom portion 126 ) to increase heat transfer.
- the base 130 can include a lower surface 134 configured to provide stability when the base 130 is in use, e.g., when the grid assembly 100 is placed on a counter, table top, or the bottom of a container having dry ice for freezing the grid assembly 100 .
- the lower surface 134 and the surface having the pockets 132 may be disposed at an angle from each other to improve ergonomics for the user during extraction of the cores from the tissue samples, e.g., by the coring tool of International Patent Application No. PCT/US2019/057835 that was previously incorporated by reference, or another suitable instrument.
- the base 130 is formed from a material (e.g., metal, stone, etc.) with material density and heat transfer properties suitable for maintaining the tissue samples in the wells 122 at a desired temperature.
- the base 130 can include one or more mechanical coupling features (not shown) that correspond to features on the lid 110 and/or tray 120 to provide a secure connection of the lid 110 and/or tray 120 on the base 130 .
- the base 130 can have an aperture (not shown) on a side for insertion of a thermocouple to allow monitoring of the temperature of the base 130 to ensure the tissue samples in the tray 120 remain in a frozen state (e.g., ⁇ 70° C. or less).
- the grid assembly 100 can be placed within an additional enclosure, such as a freezer or cooler, to improve heat transfer and maintain the tissue samples at a desired temperature and/or for longer term storage.
- the base 130 can be pre-chilled separately from the tray 120 and the lid 110 .
- the fresh tissues are prepared and are placed in the wells 122 .
- Optimal cutting temperature (OCT), Cryo-Gel, or other cryogenic embedding matrix may be added to the wells 122 to increase the heat transfer to the fresh tissue samples such that the OCT, Cryo-Gel, or other cryogenic embedding matrix solidifies around the samples for immobilization.
- the embedding matrix may additionally fill the perforations 124 to create a mechanical lock within the well 122 for improved immobilization of the tissue samples during core extraction with, e.g., the coring tool of International Patent Application No. PCT/US2019/057835 as previously incorporated herein, or another suitable instrument.
- the grid assembly 100 can be used to freeze the tissue samples at a slower rate than conventional methods (e.g., flash freezing), which can avoid damage to the tissue samples.
- the lid 110 can be replaced over the tray 120 , and then the subassembly of the lid 110 and the tray 120 can be removed from the base 130 for storage in a freezer.
- each individual door 114 can be opened during placement of the tissue samples and the cryogenic embedding matrix, and then closed for storage.
- the cores are stored at or below ⁇ 80° C. in a freezer.
- the subassembly of the lid 110 and the tray 120 may be placed on a pre-chilled base 130 to maintain the freezing state of the tissue samples while the cores are extracted from the tissue samples.
- the doors 114 can be opened individually to extract the cores, e.g., the coring tool of International Patent Application No. PCT/US2019/057835 as previously incorporated herein, or another suitable instrument, without exposing the tissue samples in other wells 122 to the surrounding environment.
- the barcodes 116 provide identification for the tissue sample contained in the wells 122 .
- FIG. 3 is a perspective view of a tissue sample storage container grid 200 (“grid 200 ”) configured in accordance with an embodiment of the present technology.
- the grid 200 has similarities to components of the grid assembly 100 , except the grid 200 generally combines the lid 110 and the tray 120 into a single component.
- the grid 200 includes a tray portion 220 and a lid portion 228 and can be configured to be used with a suitable base (e.g., the base 130 of the grid assembly 100 ).
- the tray portion 220 has a grid of wells 222 for retaining tissue samples therein. Although not shown in the illustrated embodiments of FIGS. 3 and 4 , the wells 222 can further include perforations similar to the perforations 124 described above.
- the lid portion 228 can be hingedly associated with the tray portion 220 such that the lid portion 228 can be selectively closed to enclose the tissue samples within the wells 222 .
- the lid portion 228 may have individual doors corresponding the position of each of the wells 222 , e.g., similar to the doors 114 described above with respect to the grid assembly 100 .
- the grid 200 can include an identification feature on the lid portion 228 and/or the base portion (not shown), e.g., a barcode, matrix code (e.g., a QR code), etc. to aid in identification of the tissue samples within the grid 200 .
- FIG. 4 is a front view of the grid 200 and shows various human-readable and computer-readable well identification features, similar to the barcodes 116 of the lid 110 described above with respect to the grid assembly 100 .
- a surface of the tray portion 220 can include human-readable well identification features, including well row markers 240 a and well column markers 240 b that can be used to identify the well 222 , e.g., to determine which well 222 contains a certain tissue sample.
- the well 222 marked “A5” may have a different tissue sample type than the well 222 marked “C2,” etc.
- the surface of the tray portion 220 can include computer-readable well identification features in addition to, or as an alternate to the human-readable well identification features.
- the computer-readable well identification features can be input to the computer by any suitable imaging device or scanner, e.g., a camera, a laser scanner, etc., and can be mounted to the coring tool of International Patent Application No. PCT/US2019/057835, as previously incorporated herein.
- the computer-readable well identification features can include a barcode-type system having vertical indicia 230 a, horizontal indicia 230 b, and separating/positioning indicia 232 .
- the vertical, horizontal, and separating/positioning indicia 230 a, 230 b, 232 can be configured to allow a computer to identify the position of each well 222 , and can be further configured for computer identification when a layer of frost has covered the grid 200 after freezing.
- the wells 222 can be identified using any suitable well identification features, such as cuts (see FIG. 5 ), markings (not shown), a series of colored portions (not shown), etc. suitable for identification by a computer (e.g., by a camera, scanner, etc.), where the camera and/or scanner unit can be coupled to a component of the grid 200 and/or positioned above the tray portion 220 to identify the wells 222 .
- suitable well identification features such as cuts (see FIG. 5 ), markings (not shown), a series of colored portions (not shown), etc. suitable for identification by a computer (e.g., by a camera, scanner, etc.), where the camera and/or scanner unit can be coupled to a component of the grid 200 and/or positioned above the tray portion 220 to identify the wells 222 .
- any of the suitable well identification features can be positioned on a fixture (e.g., the base 130 or another suitable fixture) configured to carry the tray portion 220 , such that a camera and/or scanner unit can interpret the well identifying features through the tray portion 220 , e.g., by a transparent area of the tray portion 220 aligned with the well identifying features.
- FIG. 5 is a front view of the tray portion 220 and shows an identifying corner 250 having a different configuration than the other three corners.
- the identifying corner 250 can allow the camera/scanner to determine the orientation of the tray portion 220 for identification of the position of a first well A 1 nearest the identifying corner 250 , and then relative identification of the other wells (e.g., A 2 , B 1 , etc.) in relation to the first well A 1 .
- the identifying corner 250 can be configured to interface with a corresponding feature in a fixture (e.g., a complementary feature in the base 130 or another suitable fixture) to orient the tray portion 220 relative to the fixture.
- a fixture e.g., a complementary feature in the base 130 or another suitable fixture
- a camera associated with the fixture would then be able to determine the position of the wells 222 of the tray portion 220 by the orientation of the tray portion 220 based on the identifying corner 250 .
- a further identifying feature e.g., markings, colored portions, etc. may not be required.
- the marking can be a dark border (not shown) around a first well 222 (e.g., the upper left well) which would give the camera/scanner an orientation of the tray portion 220 for relative identification of the other wells 222 .
- each of the wells could include a border to assist in identification of the well positions by the camera/scanner.
- the color coding can include a partial or full colored border around the opening of the well 222 , colored paneling within the well 222 , a colored area on the lid portion 228 corresponding to the position of the well 222 , or any combination thereof.
- the OCT embedding matrix or other freezing media within the well 222 can include dyes/pigments used to identify the position of each well 222 , and may be included with the grid 200 during manufacturing, such that a user would add a tissue sample to a pre-colored freezing media and then freeze the grid 200 with the identifying freezing media and tissue samples in each of the wells 222 .
- the well 222 corresponding to human-readable position “B4” can have a specific color hue to allow identification of the well 222 position by the computer.
- the well position data can be combined by the computer with image data from a tool, (e.g., the coring tool of International Patent Application No. PCT/US2019/057835, as previously incorporated herein), to determine which well 222 the tool is sampling.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Mechanical Engineering (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
Description
- The present application claims priority to U.S. Provisional Patent Application No.: 63/039,679, titled “PLATFORM FOR FREEZING AND STORING TISSUE,” filed Jun. 16, 2020, the disclosure of which is hereby incorporated by reference in its entirety.
- This present technology was made with government support under R33 CA191135, R01 DK103849, R21 GM111439, R44 GM122097, R42 HG010855, and U01 CA246503, awarded by National Institutes of Health. The government has certain rights in the invention.
- The present technology generally relates to systems and methods for storing cryogenic tissue samples in a storage container and identifying the samples.
- Histological and molecular intra-tissue heterogeneity is present in virtually every disease, including cancer and organ injury. This heterogeneity may account for many therapeutic failures (particularly in cancer), and is shifting the paradigm that multiple, as opposed to single, biopsies are needed to optimize personalized medical care. There are powerful high throughput pre-analytical sample preparation and analytical platforms to study intracellular processes and their alterations in tissues, including molecular intratissue heterogeneity in cancer and organ injury. Freezing or paraffin embedding of formalin fixed tissues (FFPE) is a common way to preserve and store samples for analysis (e.g. surgical specimens for pathologist evaluation).
- Advances in high throughput (HT) sample preparation and analytical technologies are providing opportunities to study intra-tissue heterogeneity, leading to discoveries of disease biomarkers. Tissue biopsies are among the most common medical procedures used to establish diagnosis. Historically, tissue biopsies were primarily used for histology. More recently, with increasing understanding of molecular basis of disease, tissue samples are being used in personalized medicine where treatments are based on discoveries of molecular biomarkers.
- Space shortages in deep freezers (e.g., −80° C. or less) can require discarding of older samples to make room for new samples. Cryogenic tissues are typically stored in tubes (often 1.5 ml), but typically only a small space is occupied on the bottom tip of the tube, leading to inefficient freezer storage. The frozen tissue samples freeze attached to the bottom of the tube, and removal often requires a degree of thawing. Repeated thawing and freezing can cause sample degradation.
- Many aspects of the present technology can be better understood with reference to the following drawings. The components in the drawings are not necessarily drawn to scale. Instead, emphasis is placed on illustrating clearly the principles of the present technology. Furthermore, components can be shown as transparent in certain views for clarity of illustration only and not to indicate that the component is necessarily transparent. Components may also be shown schematically.
-
FIG. 1 is an exploded perspective view of a tissue sample storage container grid assembly configured in accordance with an embodiment of the present technology. -
FIG. 2 is an enlarged perspective view of the tissue sample storage container ofFIG. 1 , showing a compartment lid open. -
FIG. 3 is a perspective view of a tissue sample storage container grid configured in accordance with an embodiment of the present technology. -
FIG. 4 is a front view of the tissue sample storage container grid ofFIG. 3 . -
FIG. 5 is a front view of a tray portion of the tissue sample storage container grid ofFIG. 3 , showing an identifying corner. - The present technology is directed to a cryogenic tissue sample storage system having a tissue sample storage container grid. Storage systems of the present technology increase the density of tissue samples per volume to allow a greater number of samples to be stored in freezers. The relatively shallow storage wells increase accessibility of the samples and avoid the degradation of a thaw and refreeze cycle of the cryogenic sample. Under certain testing protocols, it is necessary to maintain the cores in a frozen state to preserve the normal and/or diseased cell conditions, preventing the cells from changing state during preparation, transportation, and/or storage of the samples. Tissue sample storage containers configured in accordance with the present technology maintain the cores in a frozen state and provide catalog information for identification of the cores in each well.
- Frozen tissue sample blocks from which cores are extracted by a coring tool (e.g., the coring tools described in International Patent Application No. PCT/US2019/057835, filed Oct. 24, 2019, the entirety of which is incorporated by reference herein), may be contained within a grid of cryogenically temperature-controlled sample wells. Storage container grids configured in accordance with the present technology may be adapted to store and organize tissue samples in a space-efficient manner for coring and testing. The frozen tissue samples can be kept in a frozen state by any suitable heat removal method, such as placing the storage grid in an enclosure (e.g., a freezer) or a chilled component, and/or contacting the storage grid with a cold substance (e.g., solid carbon dioxide, “dry ice,” etc.). In some embodiments, the storage grid may have active heat removal to keep the tissue samples at a specified temperature for long-term storage.
-
FIG. 1 is an exploded perspective view of a tissue sample storage container grid assembly 100 (“grid assembly 100”) configured in accordance with an embodiment of the present technology. Thegrid assembly 100 includes alid 110, atray 120, and abase 130. The components of thegrid assembly 100 are separable, such that one or more components may be used without the full assembly, e.g., using thelid 110 and thetray 120 together and placing the subassembly of thelid 110 and thetray 120 in a freezer without thebase 130. - The
lid 110 has an array ofindividual openings 112 generally arranged in a grid along the surface of thelid 110. Each of theopenings 112 can include a cover or semi- to fullytransparent door 114 configured to occlude thecorresponding opening 112 when the opening is not in use, after the tissue samples have been placed within thegrid assembly 100, during storage, etc. Thedoor 114 can be hingedly coupled to the lid 110 (as shown inFIG. 2 ) or can be detachable from thelid 110. Thelid 110 can further include an identification feature (e.g., a barcode 116) near each of theopenings 112 configured to identify the tissue sample stored within a particular position of thegrid assembly 100. - The
tray 120 includes an array ofwells 122 generally corresponding to the position of theopenings 112 of thelid 110. Thewells 122 are sized and configured to enclose tissue samples together with thedoors 114. Although eachwell 122 is shown in the Figures having a rounded-rectangular shape, the wells can have any suitable shape, such as circular, elliptical, triangular, geometric, etc. Eachwell 122 is defined bywalls 125 extending from a perimeter aligned with theopenings 112, and abottom portion 126. Thewall 125 and/or thebottom portion 126 of thewells 122 can include one ormore perforations 124 to increase the heat transfer from the tissue samples inside of thewells 122 to thebase 130, e.g., while extracting heat during freezing, or to another heat transfer component. Thetray 120 can include one or more mechanical coupling features (not shown) that correspond to features on thelid 110 and provide a removable coupling of thelid 110 on thetray 120. In this regard the subassembly of thelid 110 and thetray 120 can be removed from thebase 130 without separating thelid 110 and thetray 120, retaining the tissue samples within thewells 122. Thetray 120 can be formed from plastic sheets (e.g., polystyrene, polycarbonate, etc.) and molded into skirted rectangular trays that contain thewells 122 for storing the tissue samples. Thelid 110 andtray 120 can be made from any suitable material, such as a plastic (e.g., polystyrene, polypropylene, etc.), metal, etc. - The
base 130 includes an array ofpockets 132 generally corresponding to the position of theopenings 112 of thelid 110 and thewells 122 of thetray 120. Thepockets 132 are sized and configured to receive thewells 122 therein, and may contact one or more of the outer surfaces of the wells 122 (e.g., thewalls 125 and/or the bottom portion 126) to increase heat transfer. As shown inFIG. 1 , thebase 130 can include alower surface 134 configured to provide stability when thebase 130 is in use, e.g., when thegrid assembly 100 is placed on a counter, table top, or the bottom of a container having dry ice for freezing thegrid assembly 100. In this regard, thelower surface 134 and the surface having thepockets 132 may be disposed at an angle from each other to improve ergonomics for the user during extraction of the cores from the tissue samples, e.g., by the coring tool of International Patent Application No. PCT/US2019/057835 that was previously incorporated by reference, or another suitable instrument. In some embodiments, thebase 130 is formed from a material (e.g., metal, stone, etc.) with material density and heat transfer properties suitable for maintaining the tissue samples in thewells 122 at a desired temperature. In a similar manner as with thelid 110 andtray 120 described above, the base 130 can include one or more mechanical coupling features (not shown) that correspond to features on thelid 110 and/ortray 120 to provide a secure connection of thelid 110 and/ortray 120 on thebase 130. The base 130 can have an aperture (not shown) on a side for insertion of a thermocouple to allow monitoring of the temperature of the base 130 to ensure the tissue samples in thetray 120 remain in a frozen state (e.g., −70° C. or less). - The
grid assembly 100 can be placed within an additional enclosure, such as a freezer or cooler, to improve heat transfer and maintain the tissue samples at a desired temperature and/or for longer term storage. During placement of the fresh tissue samples within thegrid assembly 100, the base 130 can be pre-chilled separately from thetray 120 and thelid 110. After chilling of thebase 130, the fresh tissues are prepared and are placed in thewells 122. Optimal cutting temperature (OCT), Cryo-Gel, or other cryogenic embedding matrix may be added to thewells 122 to increase the heat transfer to the fresh tissue samples such that the OCT, Cryo-Gel, or other cryogenic embedding matrix solidifies around the samples for immobilization. In this regard, the embedding matrix may additionally fill theperforations 124 to create a mechanical lock within the well 122 for improved immobilization of the tissue samples during core extraction with, e.g., the coring tool of International Patent Application No. PCT/US2019/057835 as previously incorporated herein, or another suitable instrument. In other embodiments, thegrid assembly 100 can be used to freeze the tissue samples at a slower rate than conventional methods (e.g., flash freezing), which can avoid damage to the tissue samples. If thelid 110 is removed for placement of the tissue samples and the OCT embedding matrix in thewells 122, thelid 110 can be replaced over thetray 120, and then the subassembly of thelid 110 and thetray 120 can be removed from thebase 130 for storage in a freezer. In other embodiments, eachindividual door 114 can be opened during placement of the tissue samples and the cryogenic embedding matrix, and then closed for storage. In some embodiments, the cores are stored at or below −80° C. in a freezer. - To access the tissue samples for core extraction and testing, e.g., following storage, the subassembly of the
lid 110 and thetray 120 may be placed on apre-chilled base 130 to maintain the freezing state of the tissue samples while the cores are extracted from the tissue samples. During extraction, thedoors 114 can be opened individually to extract the cores, e.g., the coring tool of International Patent Application No. PCT/US2019/057835 as previously incorporated herein, or another suitable instrument, without exposing the tissue samples inother wells 122 to the surrounding environment. In some embodiments, thebarcodes 116 provide identification for the tissue sample contained in thewells 122. After the cores are extracted from the tissue samples, the subassembly of thelid 110 and thetray 120 can be removed from the base 130 are placed back in the freezer for further testing. -
FIG. 3 is a perspective view of a tissue sample storage container grid 200 (“grid 200”) configured in accordance with an embodiment of the present technology. Thegrid 200 has similarities to components of thegrid assembly 100, except thegrid 200 generally combines thelid 110 and thetray 120 into a single component. Thegrid 200 includes atray portion 220 and alid portion 228 and can be configured to be used with a suitable base (e.g., thebase 130 of the grid assembly 100). Thetray portion 220 has a grid ofwells 222 for retaining tissue samples therein. Although not shown in the illustrated embodiments ofFIGS. 3 and 4 , thewells 222 can further include perforations similar to theperforations 124 described above. Thelid portion 228 can be hingedly associated with thetray portion 220 such that thelid portion 228 can be selectively closed to enclose the tissue samples within thewells 222. In other embodiments, thelid portion 228 may have individual doors corresponding the position of each of thewells 222, e.g., similar to thedoors 114 described above with respect to thegrid assembly 100. Thegrid 200 can include an identification feature on thelid portion 228 and/or the base portion (not shown), e.g., a barcode, matrix code (e.g., a QR code), etc. to aid in identification of the tissue samples within thegrid 200. -
FIG. 4 is a front view of thegrid 200 and shows various human-readable and computer-readable well identification features, similar to thebarcodes 116 of thelid 110 described above with respect to thegrid assembly 100. In one example, a surface of thetray portion 220 can include human-readable well identification features, including well rowmarkers 240 a andwell column markers 240 b that can be used to identify the well 222, e.g., to determine which well 222 contains a certain tissue sample. For example, the well 222 marked “A5” may have a different tissue sample type than the well 222 marked “C2,” etc. The surface of thetray portion 220 can include computer-readable well identification features in addition to, or as an alternate to the human-readable well identification features. The computer-readable well identification features can be input to the computer by any suitable imaging device or scanner, e.g., a camera, a laser scanner, etc., and can be mounted to the coring tool of International Patent Application No. PCT/US2019/057835, as previously incorporated herein. The computer-readable well identification features can include a barcode-type system havingvertical indicia 230 a,horizontal indicia 230 b, and separating/positioning indicia 232. The vertical, horizontal, and separating/positioning indicia grid 200 after freezing. - In other embodiments, the
wells 222 can be identified using any suitable well identification features, such as cuts (seeFIG. 5 ), markings (not shown), a series of colored portions (not shown), etc. suitable for identification by a computer (e.g., by a camera, scanner, etc.), where the camera and/or scanner unit can be coupled to a component of thegrid 200 and/or positioned above thetray portion 220 to identify thewells 222. In other embodiments, any of the suitable well identification features (e.g., thewell row markers 240 a, thewell column markers 240 b, thevertical indicia 230 a, thehorizontal indicia 230 b, the separating/positioning indicia 232, markings, colored portions, borders, etc.) can be positioned on a fixture (e.g., the base 130 or another suitable fixture) configured to carry thetray portion 220, such that a camera and/or scanner unit can interpret the well identifying features through thetray portion 220, e.g., by a transparent area of thetray portion 220 aligned with the well identifying features. -
FIG. 5 is a front view of thetray portion 220 and shows an identifyingcorner 250 having a different configuration than the other three corners. The identifyingcorner 250 can allow the camera/scanner to determine the orientation of thetray portion 220 for identification of the position of a first well A1 nearest the identifyingcorner 250, and then relative identification of the other wells (e.g., A2, B1, etc.) in relation to the first well A1. The identifyingcorner 250 can be configured to interface with a corresponding feature in a fixture (e.g., a complementary feature in the base 130 or another suitable fixture) to orient thetray portion 220 relative to the fixture. A camera associated with the fixture would then be able to determine the position of thewells 222 of thetray portion 220 by the orientation of thetray portion 220 based on the identifyingcorner 250. In these embodiments, a further identifying feature (e.g., markings, colored portions, etc.) may not be required. - In embodiments with markings, the marking can be a dark border (not shown) around a first well 222 (e.g., the upper left well) which would give the camera/scanner an orientation of the
tray portion 220 for relative identification of theother wells 222. In further embodiments, each of the wells could include a border to assist in identification of the well positions by the camera/scanner. In embodiments with colored portions, the color coding can include a partial or full colored border around the opening of the well 222, colored paneling within the well 222, a colored area on thelid portion 228 corresponding to the position of the well 222, or any combination thereof. In further embodiments, the OCT embedding matrix or other freezing media within the well 222 can include dyes/pigments used to identify the position of each well 222, and may be included with thegrid 200 during manufacturing, such that a user would add a tissue sample to a pre-colored freezing media and then freeze thegrid 200 with the identifying freezing media and tissue samples in each of thewells 222. For example, the well 222 corresponding to human-readable position “B4” can have a specific color hue to allow identification of the well 222 position by the computer. In any of the well identification embodiments described above, the well position data can be combined by the computer with image data from a tool, (e.g., the coring tool of International Patent Application No. PCT/US2019/057835, as previously incorporated herein), to determine which well 222 the tool is sampling. - The above detailed descriptions of embodiments of the technology are not intended to be exhaustive or to limit the technology to the precise form disclosed above. Although specific embodiments of, and examples for, the technology are described above for illustrative purposes, various equivalent modifications are possible within the scope of the technology, as those skilled in the relevant art will recognize. For example, while steps are presented in a given order, alternative embodiments may perform steps in a different order. Moreover, the various embodiments described herein may also be combined to provide further embodiments. Reference herein to “one embodiment,” “an embodiment,” or similar formulations means that a particular feature, structure, operation, or characteristic described in connection with the embodiment can be included in at least one embodiment of the present technology. Thus, the appearances of such phrases or formulations herein are not necessarily all referring to the same embodiment.
- For ease of reference, identical reference numbers are used to identify similar or analogous components or features throughout this disclosure, but the use of the same reference number does not imply that the features should be construed to be identical. Indeed, in many examples described herein, identically numbered features have a plurality of embodiments that are distinct in structure and/or function from each other. Furthermore, the same shading may be used to indicate materials in cross section that can be compositionally similar, but the use of the same shading does not imply that the materials should be construed to be identical unless specifically noted herein.
- Moreover, unless the word “or” is expressly limited to mean only a single item exclusive from the other items in reference to a list of two or more items, then the use of “or” in such a list is to be interpreted as including (a) any single item in the list, (b) all of the items in the list, or (c) any combination of the items in the list. Where the context permits, singular or plural terms may also include the plural or singular term, respectively. As used herein, with respect to measurements, “about” means +/−5%. Additionally, the term “comprising” is used throughout to mean including at least the recited feature(s) such that any greater number of the same feature and/or additional types of other features are not precluded. Directional terms, such as “upper,” “lower,” “front,” “back,” “vertical,” and “horizontal,” may be used herein to express and clarify the relationship between various elements. It should be understood that such terms do not denote absolute orientation. Further, while advantages associated with certain embodiments of the technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the technology. Accordingly, the disclosure and associated technology can encompass other embodiments not expressly shown or described herein.
Claims (22)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/348,504 US20210386056A1 (en) | 2020-06-16 | 2021-06-15 | Tissue sample coring system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063039679P | 2020-06-16 | 2020-06-16 | |
US17/348,504 US20210386056A1 (en) | 2020-06-16 | 2021-06-15 | Tissue sample coring system |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210386056A1 true US20210386056A1 (en) | 2021-12-16 |
Family
ID=78824001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/348,504 Pending US20210386056A1 (en) | 2020-06-16 | 2021-06-15 | Tissue sample coring system |
Country Status (1)
Country | Link |
---|---|
US (1) | US20210386056A1 (en) |
-
2021
- 2021-06-15 US US17/348,504 patent/US20210386056A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8163252B2 (en) | Kit for taking biopsies, autopsies, excisions, and resections and methods thereof | |
KR102609487B1 (en) | Biopsy tissue sample cassettes and related systems and methods | |
JP4977817B2 (en) | Storage unit and transfer system for storing and arranging biological samples | |
US8283134B2 (en) | Cassette for fixing, embedding and slicing biological tissues and method of using the cassette | |
US8796038B2 (en) | Method for orienting tissue samples on a microtome sectionable biopsy support | |
McDonald | High-pressure freezing for preservation of high resolution fine structure and antigenicity for immunolabeling | |
US20060121596A1 (en) | Core sampling device intended to assemble tissue arrays | |
DK2803005T3 (en) | Device and method for storage and organization of biological test cassettes | |
JP2015524918A (en) | Tissue sample container and method | |
US20210386056A1 (en) | Tissue sample coring system | |
CN108112576A (en) | A kind of combined type freezing storing box | |
US11726013B2 (en) | Pathology assembly | |
Villouta et al. | A device for the controlled cooling and freezing of excised plant specimens during magnetic resonance imaging | |
Watkins | Cryosectioning | |
CN111699352B (en) | Cryogenic storage system and related method | |
CN210729602U (en) | Fetching device for freezing tube | |
US20120258027A1 (en) | Histology Slide and Paraffin Block Protector and Transport Sleeve | |
CN213283098U (en) | Tissue sample taking device applied to biological sample library | |
CN216035703U (en) | Novel paper cryopreserved box | |
CN214525018U (en) | Section storage device | |
EP3177905B1 (en) | Method for providing a tissue array using a carrier medium | |
Garcés | Mohs Micrographic Surgery | |
Snell et al. | Breast Tissue Banking |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: UNIVERSITY OF WASHINGTON, WASHINGTON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BOMSZTYK, KAROL;MAR, DANIEL;SCHEUERMAN, STEPHEN;AND OTHERS;SIGNING DATES FROM 20210617 TO 20210701;REEL/FRAME:057065/0817 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT, MARYLAND Free format text: CONFIRMATORY LICENSE;ASSIGNOR:UNIVERSITY OF WASHINGTON;REEL/FRAME:065776/0908 Effective date: 20210803 |